跳转至内容
Merck
CN

SAB5200058

Monoclonal Anti-KCNA4 antibody produced in mouse

clone S13-31, 1 mg/mL, purified immunoglobulin

别名:

Anti-HBK4, Anti-HK1, Anti-HPCN2, Anti-HUKII, Anti-KCNA4, Anti-Kv1.4 K+ channel, S13-31

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
S13-31, monoclonal
Application:
IHC, IP, WB
Citations:
2
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

mouse

Quality Level

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

S13-31, monoclonal

form

buffered aqueous glycerol solution

mol wt

antigen predicted mol wt 98 kDa

species reactivity

mouse, human, rat

concentration

1 mg/mL

technique(s)

immunohistochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable

isotype

IgG1

NCBI accession no.

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

rat ... Kcna4(25469)

Immunogen

Synthetic peptide 13-37 of rat Kv1.4 (NSHMPYGYAAQARARERERLAHSR)

Biochem/physiol Actions

Detects ~98 kDa.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Solution in PBS, pH 7.4, 50% glycerol, and 0.09% sodium azide


Still not finding the right product?

试用我们的 产品选型工具 工具缩小选择范围


存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Wenfeng Li et al.
Medical oncology (Northwood, London, England), 31(9), 118-118 (2014-07-30)
Enhanced glycolysis is a common trait of many types of human cancers. This study was to detect the expression pattern of three regulatory enzymes during glycolysis in esophageal squamous cell carcinoma (ESCC) and to investigate their correlation with patients' outcome
Morgan Stathem et al.
Journal of cellular biochemistry, 116(1), 67-80 (2014-08-26)
Cancer therapeutics has seen an emergence and re-emergence of two metabolic fields in recent years, those of bioactive sphingolipids and glycolytic metabolism. Anaerobic glycolysis and its implications in cancer have been at the forefront of cancer research for over 90



全球贸易项目编号

货号GTIN
SAB5200058-100UG04061836274306